Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups

SIMPLE SUMMARY: Tamoxifen is a drug often used to treat the most common type of breast cancer. Its metabolite endoxifen is formed by the liver enzyme CYP2D6, whose activity is variable and depends on a patient’s genetic profile. The frequency of CYP2D6 variants with different functional enzymatic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller-Schoell, Anna, Michelet, Robin, Klopp-Schulze, Lena, van Dyk, Madelé, Mürdter, Thomas E., Schwab, Matthias, Joerger, Markus, Huisinga, Wilhelm, Mikus, Gerd, Kloft, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157244/
https://www.ncbi.nlm.nih.gov/pubmed/34069810
http://dx.doi.org/10.3390/cancers13102432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157244/
https://www.ncbi.nlm.nih.gov/pubmed/34069810
http://dx.doi.org/10.3390/cancers13102432

Ejemplares similares